SONOMA PHARMACEUTICALS, INC. APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
SONOMA PHARMACEUTICALS, INC. (SNOA) reported APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition of $140.00 thousand for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-02-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition · last filed 2024-02-08
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2023-12-31 was $140.00K, a 39.91% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2023-09-30 was $130.00K, a 20.37% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2023-06-30 was $177.00K, a 17.29% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2022-12-31 was $233.00K.
| Period end | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 9 month |
|---|---|---|---|
| 2023-12-31 | $140.00K 10-Q · filed 2024-02-08 | $270.00K derived: sum of 2 quarters · filed 2024-02-08 | $447.00K derived: sum of 3 quarters · filed 2024-02-08 |
| 2023-09-30 | $130.00K 10-Q · filed 2024-02-08 | $307.00K derived: sum of 2 quarters · filed 2024-02-08 | |
| 2023-06-30 | $177.00K 10-Q · filed 2024-02-08 | ||
| 2022-12-31 | $233.00K 10-Q · filed 2024-02-08 | $341.00K derived: sum of 2 quarters · filed 2024-02-08 | $555.00K derived: sum of 3 quarters · filed 2024-02-08 |
| 2022-09-30 | $108.00K 10-Q · filed 2024-02-08 | $322.00K derived: sum of 2 quarters · filed 2024-02-08 | |
| 2022-06-30 | $214.00K 10-Q · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |